News

Acurx ($ACXP) stock higher by 3%, commences Phase2b trial

Acurx ($ACXP) stock higher by 3%, commences Phase2b trial. Coverage: https://level3trading.com/acurx-pharmaceuticals-shares-jump-10-after-reaching-phase-2b-milestone-evaluating-ibezapolstat-to-treat-c-difficle-nasdaq-acxp/

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button